Login
Subscribe
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
arthritis, disease & medicine
Image of the Day: Scorpion Venom for Arthritis
Amy Schleunes | Mar 17, 2020 | 1 min read
A mouse model of rheumatoid arthritis reveals that a tiny protein in scorpion venom can deliver steroids to affected joints.
Image of the Day: Reversing Arthritis
Amy Schleunes | Jan 28, 2020 | 1 min read
A combination of two drugs appears to restore cartilage in rats.